Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Computer-based intensity measurement assists pathologists in scoring PTEN immunohistochemistry - Clinical associations in NSCLC patients of the ETOP Lungscape cohort.

Rulle U, Tsourti Z, Casanova R, Deml KF, Verbeken E, Thunnissen E, Warth A, Cheney R, Sejda A, Speel EJ, Madsen LB, Nonaka D, Navarro A, Sansano I, Marchetti A, Finn SP, Monkhorst K, Kerr KM, Haberecker M, Wu C, Zygoura P, Kammler R, Geiger T, Gendreau S, Schulze K, Vrugt B, Wild P, Moch H, Weder W, Ciftlik AT, Dafni U, Peters S, Bubendorf L, Stahel RA, Soltermann A.

J Thorac Oncol. 2018 Sep 18. pii: S1556-0864(18)33053-3. doi: 10.1016/j.jtho.2018.08.2034. [Epub ahead of print]

PMID:
30240851
2.

Phosphatidylinositol 3-kinase p110δ expression in Merkel cell carcinoma.

Chteinberg E, Rennspiess D, Sambo R, Tauchmann S, Kelleners-Smeets NWJ, Winnepenninckx V, Speel EJ, Kurz AK, Zenke M, Zur Hausen A.

Oncotarget. 2018 Jul 3;9(51):29565-29573. doi: 10.18632/oncotarget.25619. eCollection 2018 Jul 3.

3.

The IGF pathway is activated in insulinomas but downregulated in metastatic disease.

Henfling M, Perren A, Schmitt AM, Saddig CM, Starke AA, Riedl RG, Versleijen-Jonkers YMH, Sprij-Mooij DM, Ramaekers FCS, Hofland L, Speel EM.

Endocr Relat Cancer. 2018 Jul 18. pii: ERC-18-0222. doi: 10.1530/ERC-18-0222. [Epub ahead of print]

PMID:
30021864
4.

Vismodegib-resistant basal cell carcinomas in basal cell nevus syndrome: Clinical approach and genetic analysis.

Sinx KAE, Roemen GMJM, van Zutven V, Janssen R, Speel EM, Steijlen PM, van Geel M, Mosterd K.

JAAD Case Rep. 2018 Apr 30;4(5):408-411. doi: 10.1016/j.jdcr.2017.11.011. eCollection 2018 Jun. No abstract available.

5.

Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.

Walter RFH, Rozynek P, Casjens S, Werner R, Mairinger FD, Speel EJM, Zur Hausen A, Meier S, Wohlschlaeger J, Theegarten D, Behrens T, Schmid KW, Brüning T, Johnen G.

PLoS One. 2018 May 31;13(5):e0195716. doi: 10.1371/journal.pone.0195716. eCollection 2018.

6.

New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.

Derks JL, Leblay N, Lantuejoul S, Dingemans AC, Speel EM, Fernandez-Cuesta L.

J Thorac Oncol. 2018 Jun;13(6):752-766. doi: 10.1016/j.jtho.2018.02.002. Epub 2018 Feb 14. Review. Erratum in: J Thorac Oncol. 2018 Aug;13(8):1229.

PMID:
29454048
7.

Detection of Merkel Cell Polyomavirus in Seborrheic Keratosis.

Hillen LM, Rennspiess D, Speel EJ, Haugg AM, Winnepenninckx V, Zur Hausen A.

Front Microbiol. 2018 Jan 9;8:2648. doi: 10.3389/fmicb.2017.02648. eCollection 2017.

8.

Female urothelial cell carcinoma in a failed kidney graft of a male recipient.

de Jongh HJJ, van Duijnhoven EM, Rüland A, Abdul Hamid MMA, Speel EJM, van de Beek K.

Neth J Med. 2017 Oct;75(8):354-356.

9.

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

Letovanec I, Finn S, Zygoura P, Smyth P, Soltermann A, Bubendorf L, Speel EJ, Marchetti A, Nonaka D, Monkhorst K, Hager H, Martorell M, Sejda A, Cheney R, Hernandez-Losa J, Verbeken E, Weder W, Savic S, Di Lorito A, Navarro A, Felip E, Warth A, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dienemann H, Dziadziuszko R, Vansteenkiste J, O'Brien C, Geiger T, Sherlock J, Schageman J, Dafni U, Kammler R, Kerr K, Thunnissen E, Stahel R, Peters S; European Thoracic Oncology Platform Lungscape Consortium.

J Thorac Oncol. 2018 Mar;13(3):413-425. doi: 10.1016/j.jtho.2017.11.117. Epub 2017 Nov 27.

PMID:
29191776
10.

Oncogenic Viruses in Skull Base Chordomas.

Yakkioui Y, Speel EM, Van Overbeeke JJ, Boderie MJM, Pujari S, Hausen AZ, Wolffs PFG, Temel Y.

World Neurosurg. 2018 Apr;112:e7-e13. doi: 10.1016/j.wneu.2017.11.117. Epub 2017 Nov 28.

PMID:
29191533
11.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S; ETOP Lungscape Consortium.

Ann Oncol. 2018 Jan 1;29(1):200-208. doi: 10.1093/annonc/mdx629.

PMID:
29186353
12.

Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease.

Derks J, van Suylen RJ, Thunnissen E, den Bakker M, Groen H, Smit E, Damhuis R, van den Broek E, Speel EJ, Dingemans AC.

Eur Respir J. 2017 Oct 26;50(4). pii: 1701658. doi: 10.1183/13993003.01658-2017. Print 2017 Oct. No abstract available.

PMID:
29074548
13.

Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.

Derks JL, Leblay N, Thunnissen E, van Suylen RJ, den Bakker M, Groen HJM, Smit EF, Damhuis R, van den Broek EC, Charbrier A, Foll M, McKay JD, Fernandez-Cuesta L, Speel EM, Dingemans AC; PALGA-Group.

Clin Cancer Res. 2018 Jan 1;24(1):33-42. doi: 10.1158/1078-0432.CCR-17-1921. Epub 2017 Oct 24.

PMID:
29066508
14.

Prevalence of high-risk human papillomavirus infection and cancer gene mutations in nonmalignant tonsils.

Ilmarinen T, Munne P, Hagström J, Haglund C, Auvinen E, Virtanen EI, Haesevoets A, Speel EJM, Aaltonen LM.

Oral Oncol. 2017 Oct;73:77-82. doi: 10.1016/j.oraloncology.2017.08.010. Epub 2017 Aug 18.

PMID:
28939080
15.

Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.

Bubendorf L, Dafni U, Schöbel M, Finn SP, Tischler V, Sejda A, Marchetti A, Thunnissen E, Verbeken EK, Warth A, Sansano I, Cheney R, Speel EJM, Nonaka D, Monkhorst K, Hager H, Martorell M, Savic S, Kerr KM, Tan Q, Tsourti Z, Geiger TR, Kammler R, Schulze K, Das-Gupta A, Shames D, Peters S, Stahel RA; Lungscape Consortium.

Lung Cancer. 2017 Sep;111:143-149. doi: 10.1016/j.lungcan.2017.07.021. Epub 2017 Jul 22.

PMID:
28838386
16.

Bone invasion by oral squamous cell carcinoma: Molecular alterations leading to osteoclastogenesis - a review of literature.

Vaassen LAA, Speel EM, Kessler PAWH.

J Craniomaxillofac Surg. 2017 Sep;45(9):1464-1471. doi: 10.1016/j.jcms.2017.04.012. Epub 2017 Apr 27. Review.

PMID:
28756966
17.

Corrigendum to "Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging" [Radiother Oncol 113 (2014) 324-30].

Velazquez ER, Hoebers F, Aerts HJWL, Rietbergen MM, Brakenhoff RH, Leemans RC, Speel EJ, Straetmans J, Kremer B, Lambin P.

Radiother Oncol. 2017 Aug;124(2):337-338. doi: 10.1016/j.radonc.2017.06.017. Epub 2017 Jul 11. No abstract available.

PMID:
28709696
18.

Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma.

Sauer CM, Haugg AM, Chteinberg E, Rennspiess D, Winnepenninckx V, Speel EJ, Becker JC, Kurz AK, Zur Hausen A.

Crit Rev Oncol Hematol. 2017 Aug;116:99-105. doi: 10.1016/j.critrevonc.2017.05.009. Epub 2017 Jun 3. Review.

19.

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?

Derks JL, van Suylen RJ, Thunnissen E, den Bakker MA, Groen HJ, Smit EF, Damhuis RA, van den Broek EC, Speel EM, Dingemans AC; PALGA group.

Eur Respir J. 2017 Jun 1;49(6). pii: 1601838. doi: 10.1183/13993003.01838-2016. Print 2017 Jun.

20.

Chromosome instability in tumor resection margins of primary OSCC is a predictor of local recurrence.

Pierssens DDCG, Borgemeester MC, van der Heijden SJH, Peutz-Kootstra CJ, Ruland AM, Haesevoets AM, Kessler PAWH, Kremer B, Speel EM.

Oral Oncol. 2017 Mar;66:14-21. doi: 10.1016/j.oraloncology.2016.12.029. Epub 2017 Jan 6.

PMID:
28249643
21.

Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.

van der Wekken AJ, Pelgrim R, 't Hart N, Werner N, Mastik MF, Hendriks L, van der Heijden EHFM, Looijen-Salamon M, de Langen AJ, Staal-van den Brekel J, Riemersma S, van den Borne BE, Speel EJM, Dingemans AC, Hiltermann TJN, van den Berg A, Timens W, Schuuring E, Groen HJM.

Clin Cancer Res. 2017 Aug 1;23(15):4251-4258. doi: 10.1158/1078-0432.CCR-16-1631. Epub 2017 Feb 9.

22.

PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer.

van Loon J, Even AJG, Aerts HJWL, Öllers M, Hoebers F, van Elmpt W, Dubois L, Dingemans AC, Lalisang RI, Kempers P, Brans B, Winnepenninckx V, Speel EJ, Thunnissen E, Smits KM, Boellaard R, Vugts DJ, De Ruysscher D, Lambin P.

Radiother Oncol. 2017 Feb;122(2):267-273. doi: 10.1016/j.radonc.2016.11.020. Epub 2016 Dec 21.

PMID:
28012793
23.

Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.

Swarts DR, Rudelius M, Claessen SM, Cleutjens JP, Seidl S, Volante M, Ramaekers FC, Speel EJ.

Histopathology. 2017 Feb;70(3):412-422. doi: 10.1111/his.13096. Epub 2016 Nov 23.

PMID:
27701763
24.

HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.

Speel EJ.

Recent Results Cancer Res. 2017;206:57-72. Review.

PMID:
27699529
25.

Postzygotic mosaicism in basal cell naevus syndrome.

Reinders MGHC, Boersma HJ, Leter EM, Vreeburg M, Paulussen ADC, Arits AHMM, Roemen GMJM, Speel EJM, Steijlen PM, van Geel M, Mosterd K.

Br J Dermatol. 2017 Jul;177(1):249-252. doi: 10.1111/bjd.15082. Epub 2017 Jun 6.

PMID:
27658957
26.

Frequent detection of human polyomavirus 6 in keratoacanthomas.

Beckervordersandforth J, Pujari S, Rennspiess D, Speel EJ, Winnepenninckx V, Diaz C, Weyers W, Haugg AM, Kurz AK, Zur Hausen A.

Diagn Pathol. 2016 Jul 7;11(1):58. doi: 10.1186/s13000-016-0509-z.

27.

Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas.

Buishand FO, Arkesteijn GJ, Feenstra LR, Oorsprong CW, Mestemaker M, Starke A, Speel EJ, Kirpensteijn J, Mol JA.

Stem Cells Dev. 2016 Jun 1;25(11):826-35. doi: 10.1089/scd.2016.0032. Epub 2016 May 5.

28.

Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

O'Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, Lee N, Riaz N, Pei X, Koyfman SA, Adelstein D, Burkey BB, Friborg J, Kristensen CA, Gothelf AB, Hoebers F, Kremer B, Speel EJ, Bowles DW, Raben D, Karam SD, Yu E, Xu W.

Lancet Oncol. 2016 Apr;17(4):440-451. doi: 10.1016/S1470-2045(15)00560-4. Epub 2016 Feb 27.

PMID:
26936027
29.

Refining the Diagnosis of Congenital Nephrotic Syndrome on Long-term Stored Tissue: c.1097G>A (p.(Arg366His)) WT1 Mutation Causing Denys Drash Syndrome.

Hillen LM, Kamsteeg EJ, Schoots J, Tiebosch AT, Speel EJ, Roemen GM, Peutz-Koostra CJ, Stumpel CT.

Fetal Pediatr Pathol. 2016;35(2):112-9. doi: 10.3109/15513815.2016.1139018. Epub 2016 Feb 16.

PMID:
26882358
30.

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers.

Derks JL, Speel EJ, Dingemans AM.

J Thorac Oncol. 2016 Feb;11(2):e25-6. doi: 10.1016/j.jtho.2015.10.017. No abstract available.

31.

A Population-Based Analysis of Application of WHO Nomenclature in Pathology Reports of Pulmonary Neuroendocrine Tumors.

Derks JL, van Suylen RJ, Thunnissen E, den Bakker MA, Smit EF, Groen HJ, Speel EJ, Dingemans AM.

J Thorac Oncol. 2016 Apr;11(4):593-602. doi: 10.1016/j.jtho.2015.12.106. Epub 2016 Jan 9.

32.

Neuroendocrine Cancer of the Lung: A Diagnostic Puzzle.

Derks JL, Speel EJ, Thunnissen E, van Suylen RJ, Buikhuisen WA, van Velthuysen ML, Dingemans AM.

J Thorac Oncol. 2016 Mar;11(3):e35-8. doi: 10.1016/j.jtho.2015.10.013. Epub 2015 Dec 24.

33.

Clinical features of large cell neuroendocrine carcinoma: a population-based overview.

Derks JL, Hendriks LE, Buikhuisen WA, Groen HJ, Thunnissen E, van Suylen RJ, Houben R, Damhuis RA, Speel EJ, Dingemans AM.

Eur Respir J. 2016 Feb;47(2):615-24. doi: 10.1183/13993003.00618-2015. Epub 2015 Nov 5.

34.

Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients.

Jóri B, Kamps R, Xanthoulea S, Delvoux B, Blok MJ, Van de Vijver KK, de Koning B, Oei FT, Tops CM, Speel EJ, Kruitwagen RF, Gomez-Garcia EB, Romano A.

Oncotarget. 2015 Dec 1;6(38):41108-22. doi: 10.18632/oncotarget.5694.

35.

Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.

Dreijerink KM, Derks JL, Cataldo I, Scarpa A, Valk GD, Speel EJ.

Front Horm Res. 2015;44:115-38. doi: 10.1159/000382138. Epub 2015 Aug 14. Review.

PMID:
26303708
36.

Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

Kuiper JL, Hendriks LE, van der Wekken AJ, de Langen AJ, Bahce I, Thunnissen E, Heideman DA, Berk Y, Buijs EJ, Speel EJ, Krouwels FH, Smit HJ, Groen HJ, Dingemans AM, Smit EF.

Lung Cancer. 2015 Sep;89(3):255-61. doi: 10.1016/j.lungcan.2015.05.023. Epub 2015 Jun 6.

PMID:
26117231
37.

Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.

Rietbergen MM, Witte BI, Velazquez ER, Snijders PJ, Bloemena E, Speel EJ, Brakenhoff RH, Kremer B, Lambin P, Leemans CR.

Br J Cancer. 2015 May 26;112(11):1733-6. doi: 10.1038/bjc.2015.139. Epub 2015 May 7.

38.

Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.

Melchers LJ, Mastik MF, Samaniego Cameron B, van Dijk BA, de Bock GH, van der Laan BF, van der Vegt B, Speel EJ, Roodenburg JL, Witjes MJ, Schuuring E.

Br J Cancer. 2015 Apr 14;112(8):1349-57. doi: 10.1038/bjc.2015.99. Epub 2015 Mar 17.

39.
40.

MK3 modulation affects BMI1-dependent and independent cell cycle check-points.

Prickaerts P, Niessen HE, Dahlmans VE, Spaapen F, Salvaing J, Vanhove J, Geijselaers C, Bartels SJ, Partouns I, Neumann D, Speel EJ, Takihara Y, Wouters BG, Voncken JW.

PLoS One. 2015 Apr 8;10(4):e0118840. doi: 10.1371/journal.pone.0118840. eCollection 2015.

41.

Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.

Rapa I, Votta A, Felice B, Righi L, Giorcelli J, Scarpa A, Speel EJ, Scagliotti GV, Papotti M, Volante M.

Neuroendocrinology. 2015;101(3):246-55. doi: 10.1159/000381454. Epub 2015 Mar 16.

PMID:
25791280
42.

Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.

Reuschenbach M, Huebbers CU, Prigge ES, Bermejo JL, Kalteis MS, Preuss SF, Seuthe IM, Kolligs J, Speel EJ, Olthof N, Kremer B, Wagner S, Klussmann JP, Vinokurova S, von Knebel Doeberitz M.

Cancer. 2015 Jun 15;121(12):1966-76. doi: 10.1002/cncr.29315. Epub 2015 Mar 2.

43.

Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).

Creytens D, van Gorp J, Ferdinande L, Speel EJ, Libbrecht L.

Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):126-33. doi: 10.1097/PDM.0000000000000041.

PMID:
25679065
44.

BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article.

Verlinden I, van den Hurk K, Clarijs R, Willig AP, Stallinga CM, Roemen GM, van den Oord JJ, zur Hausen A, Speel EJ, Winnepenninckx VJ.

Medicine (Baltimore). 2014 Dec;93(28):e285. doi: 10.1097/MD.0000000000000285. Erratum in: Medicine (Baltimore). 2015 Apr;94(14):DOI: 10.1097/01.md.0000464339.19779.8f.

45.

Detection of human polyomavirus 7 in human thymic epithelial tumors.

Rennspiess D, Pujari S, Keijzers M, Abdul-Hamid MA, Hochstenbag M, Dingemans AM, Kurz AK, Speel EJ, Haugg A, Pastrana DV, Buck CB, De Baets MH, Zur Hausen A.

J Thorac Oncol. 2015 Feb;10(2):360-6. doi: 10.1097/JTO.0000000000000390.

46.

Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.

Rios Velazquez E, Hoebers F, Aerts HJ, Rietbergen MM, Brakenhoff RH, Leemans RC, Speel EJ, Straetmans J, Kremer B, Lambin P.

Radiother Oncol. 2014 Dec;113(3):324-30. doi: 10.1016/j.radonc.2014.09.005. Epub 2014 Oct 24. Erratum in: Radiother Oncol. 2017 Aug;124(2):337-338.

47.

A let-7 microRNA polymorphism in the KRAS 3'-UTR is prognostic in oropharyngeal cancer.

De Ruyck K, Duprez F, Ferdinande L, Mbah C, Rios-Velazquez E, Hoebers F, Praet M, Deron P, Bonte K, Speel EJ, Libbrecht L, De Neve W, Lambin P, Thierens H.

Cancer Epidemiol. 2014 Oct;38(5):591-8. doi: 10.1016/j.canep.2014.07.008. Epub 2014 Aug 12.

PMID:
25127693
48.

Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.

Olthof NC, Huebbers CU, Kolligs J, Henfling M, Ramaekers FC, Cornet I, van Lent-Albrechts JA, Stegmann AP, Silling S, Wieland U, Carey TE, Walline HM, Gollin SM, Hoffmann TK, de Winter J, Kremer B, Klussmann JP, Speel EJ.

Int J Cancer. 2015 Mar 1;136(5):E207-18. doi: 10.1002/ijc.29112. Epub 2014 Aug 14.

49.

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.

Blackhall FH, Peters S, Bubendorf L, Dafni U, Kerr KM, Hager H, Soltermann A, O'Byrne KJ, Dooms C, Sejda A, Hernández-Losa J, Marchetti A, Savic S, Tan Q, Thunnissen E, Speel EJ, Cheney R, Nonaka D, de Jong J, Martorell M, Letovanec I, Rosell R, Stahel RA.

J Clin Oncol. 2014 Sep 1;32(25):2780-7. doi: 10.1200/JCO.2013.54.5921. Epub 2014 Jul 28.

PMID:
25071109
50.

Interobserver variability for the WHO classification of pulmonary carcinoids.

Swarts DR, van Suylen RJ, den Bakker MA, van Oosterhout MF, Thunnissen FB, Volante M, Dingemans AM, Scheltinga MR, Bootsma GP, Pouwels HM, van den Borne BE, Ramaekers FC, Speel EJ.

Am J Surg Pathol. 2014 Oct;38(10):1429-36. doi: 10.1097/PAS.0000000000000300.

PMID:
25046341

Supplemental Content

Support Center